UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | Z
Number of items: 247.

A

Abad-Rodriguez, J; Ledesma, MD; Craessaerts, K; Perga, S; Medina, M; Delacourte, A; ... Dotti, CG; + view all (2004) Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol , 167 (5) 953 - 960. 10.1083/jcb.200404149.

Abou-Sleiman, PM; Healy, DG; Wood, NW; (2004) Causes of Parkinson's disease: genetics of DJ-1. CELL TISSUE RES , 318 (1) 185 - 188. 10.1007/s00441-004-0922-6.

Abou-Sleiman, PM; Healy, DG; Wood, NW; (2004) Genetic approaches to solving common diseases. J NEUROL , 251 (10) 1169 - 1172. 10.1007/s00415-004-0518-9.

Abramov, AY; Canevari, L; Duchen, MR; (2004) Amyloid beta peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. In: BIOPHYSICAL JOURNAL. (pp. 469A - 469A). BIOPHYSICAL SOCIETY

Abramov, AY; Canevari, L; Duchen, MR; (2004) beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J NEUROSCI , 24 (2) 565 - 575. 10.1523/JNEUROSCI.4042-03.2004.

Abramov, AY; Canevari, L; Duchen, MR; (2004) Calcium signals induced by amylold beta peptide and their consequences in neurons and astrocytes in culture. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH , 1742 (1-3) 81 - 87. 10.1016/j.bbamcr.2004.09.006.

Ahluwalia, J; Tinker, A; Clapp, LH; Duchen, MR; Abramov, AY; Pope, S; ... Segal, AW; + view all (2004) The large-conductance Ca2+-activated K+ channel is essential for innate immunity (Retracted article. See vol. 468, 2010). NATURE , 427 (6977) 853 - 858. 10.1038/nature02356.

Anderson, KE; (2004) Dementia in Parkinson's Disease. Curr Treat Options Neurol , 6 (3) 201 - 207.

Ansorge, O; Giunti, P; Michalik, A; Van Broeckhoven, C; Harding, B; Wood, N; Scaravilli, F; (2004) Ataxin-7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats. ANN NEUROL , 56 (3) 448 - 452.

Araki, Y; Miyagi, N; Kato, N; Yoshida, T; Wada, S; Nishimura, M; ... Suzuki, T; + view all (2004) Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates FE65-dependent gene transactivation. J Biol Chem , 279 (23) 24343 - 24354. 10.1074/jbc.M401925200.

B

Bandopadhyay, R; Kingsbury, AE; Cookson, MR; Reid, AR; Evans, IM; Hope, AD; ... Lees, AJ; + view all (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. BRAIN , 127 420 - 430. 10.1093/brain/awh054.

Bandopadhyay, R; Kingsbury, AE; Evans, IM; Miller, DW; Cookson, MR; Lees, AJ; (2004) DJ-1 immunoreactivity in control and idiopathic Parkinson's disease brain: Correlation with DJ-1 mRNA expression. In: MOVEMENT DISORDERS. (pp. S200 - S200). WILEY-LISS

Bandopadhyay, R.; Kingsbury, A.E.; Cookson, M.R.; Reid, A.R.; Evans, I.M.; Hope, A.D.; ... Lees, A.J.; + view all (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain , 127 (2) pp. 420-430. 10.1093/brain/awh054.

Bearn, J; Evans, A; Kelleher, M; Turner, K; Lees, A; (2004) Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study. DRUG ALCOHOL DEPEN , 76 (3) 305 - 310. 10.1016/j.drugalcdep.2004.06.005.

Beck, J.A.; Poulter, M.; Campbell, T.A.; Uphill, J.B.; Adamson, G.; Geddes, J.F.; ... Tabrizi, S.J.; + view all (2004) Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease. Human Molecular Genetics , 13 (12) pp. 1219-1224. 10.1093/hmg/ddh134.

Beck, JA; Poulter, M; Campbell, T; Uphill, JB; Adamson, G; Geddes, JF; ... Tabrizi, SJ; + view all (2004) Nuclear somatic mosaicism in sporadic early-onset Alzheimer's disease. In: NEUROBIOLOGY OF AGING. (pp. S54 - S54). ELSEVIER SCIENCE INC

Beck, JA; Poulter, M; Campbell, TA; Uphill, JB; Adamson, G; Geddes, JF; ... Tabrizi, SJ; + view all (2004) Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease. HUM MOL GENET , 13 (12) 1219 - 1224. 10.1093/hmg/ddh134.

Bloem, BR; Munnecke, M; Mazibrada, G; Schrag, A; Viswanathan, R; Lees, AJ; Quinn, NP; (2004) The nature of failing in progressive supranuclear palsy. In: MOVEMENT DISORDERS. (pp. 359 - 360).

Braendgaard, H; Josephs, K; Holton, J; Rossor, M; Gedde, A; Rosa, P; ... Revesz, T; + view all (2004) Neurofilament inclusion body disease (NIBD) - A new form of dementia. In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. (pp. 370 - 370). KARGER

Bremner, FD; Houlden, H; Smith, SE; (2004) Genotypic and phenotypic heterogeneity in familial microcoria. BRIT J OPHTHALMOL , 88 (4) 469 - 473. 10.1136/bjo.2003.027169.

Brown, AM; Gordon, D; Lee, H; Caudy, M; Hardy, J; Haroutunian, V; Blass, JP; (2004) Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS , 131B (1) 60 - 66. 10.1002/ajmg.b.30008.

Brown, M.; Jacobs, T.; Eickholt, B.; Ferrari, G.; Teo, M.; Monfries, C.; ... Hall, C.; + view all (2004) {alpha}2-Chimaerin, cyclin-dependent kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse. Journal of Neuroscience , 24 (41) pp. 8994-9004. 10.1523/JNEUROSCI.3184-04.2004. Green open access
file

Busby, J; O'Brien, KK; Gibson, AM; McKeith, IG; Perry, RH; Hardy, JA; ... Morris, CM; + view all (2004) Dementia with Lewy bodies: no association of polymorphisms in the human synphilin gene. NEUROGENETICS , 5 (4) 251 - 252. 10.1007/s10048-004-0188-x.

Busby, V; Goossens, S; Nowotny, P; Hamilton, G; Smemo, S; Harold, D; ... Lovestone, S; + view all (2004) alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease. NEUROMOLECULAR MEDICINE , 5 (2) 133 - 146. 10.1385/NMM:5:2:133.

C

Camacho, IE; Serneels, L; Spittaels, K; Merchiers, P; Dominguez, D; De Strooper, B; (2004) Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide. J Neurosci , 24 (48) 10908 - 10917. 10.1523/JNEUROSCI.3987-04.2004.

Canevari, L; Abramov, AY; Duchen, MR; (2004) Toxicity of amyloid beta peptide: Tales of calcium, mitochondria, and oxidative stress. NEUROCHEM RES , 29 (3) 637 - 650.

Cano, SJ; Hobart, JC; Fitzpatrick, R; Bhatia, K; Thompson, AJ; Warner, TT; (2004) Patient-based outcomes of cervical dystonia: A review of rating scales. MOVEMENT DISORD , 19 (9) 1054 - 1059. 10.1002/mds.20055.

Cano, SJ; Warner, TT; Fitzpatrick, R; Bhatia, K; Thompson, AJ; Hobart, JC; (2004) The cervical dystonia impact profile (CDIP-58): A new patient-based rating scale. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1224 - 1224). B M J PUBLISHING GROUP

Cano, SJ; Warner, TT; Linacre, JM; Bhatia, KP; Thompson, AJ; Fitzpatrick, R; Hobart, JC; (2004) Capturing the true burden of dystonia on patients - The Cervical Dystonia Impact Profile (CDIP-58). NEUROLOGY , 63 (9) 1629 - 1633.

Caparros-Lefebvre, D; Bert, P; Bolivar, V; Rigal, M; Pierrot-Deseilligny, C; Tolosa, E; Lees, A; (2004) Atypical parkinsonism in French West Indies older people. Description and prognosis factors. In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. (pp. S30 - S30). BLACKWELL PUBLISHING INC

Catania, S; Cordivari, C; Misra, P; Lees, A; (2004) Botulinum Toxin B for patients with oromandibular dystonia resistant to Botulinum Toxin A: Report of four cases. In: MOVEMENT DISORDERS. (pp. S96 - S96).

Chaudhuri, KR; Forbes, A; Grosset, D; Lees, A; Shneerson, J; Schapira, A; ... Williams, A; + view all (2004) Diagnosing restless legs syndrome (RLS) in primary care. CURR MED RES OPIN , 20 (11) 1785 - 1795. 10.1185/030079904X5472.

Church, AJ; Cardoso, F; Dale, RC; Thompson, EJ; Lees, AJ; Giovannoni, G; (2004) Chorea gravidarum: Another condition associated with Sydenham's chorea and antibasal ganglia antibodies. In: MOVEMENT DISORDERS. (pp. S53 - S54). WILEY-LISS

Clarimon, J; Singleton, A; Johnson, J; Wood, NW; Dugu, O; Lees, AJ; (2004) Homozygous deletion of the exon 4 in the Parkin in a Brazilian and a Turkish family due to independent events. In: MOVEMENT DISORDERS. (pp. S350 - S350).

Clark, LN; Afridi, S; Mejia-Santana, H; Harris, J; Louis, ED; Cote, LJ; ... Marder, K; + view all (2004) Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. MOVEMENT DISORDERS , 19 (7) 796 - 800. 10.1002/mds.20131.

Coleman, P; Kurlan, R; Crook, R; Werner, J; Hardy, J; (2004) New presenilin Alzheimer's disease case confirms the helical alignment of pathogenic mutations in transmembrane domain 5. NEUROSCIENCE LETTERS , 364 (3) 139 - 140. 10.1016/j.neulet.2004.04.030.

Cordivari, C; Misra, VP; Catania, S; Lees, AJ; (2004) New therapeutic indications for botulinum toxins. MOVEMENT DISORDERS , 19 S157 - S161. 10.1002/mds.20071.

Cordivari, C; Toms, NJ; Catania, S; Misra, VP; Lees, AJ; Brown, P; (2004) Myoclonus associated with long-standing poliomyelitis is due to central reorganization. In: MOVEMENT DISORDERS. (pp. S123 - S123).

Crowther, DC; Belorgey, D; Miranda, E; Kinghorn, KJ; Sharp, LK; Lomas, DA; (2004) Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies. Eur J Hum Genet , 12 (3) 167 - 172. 10.1038/sj.ejhg.5201127.

Crowther, DC; Kinghorn, KJ; Page, R; Lomas, DA; (2004) Therapeutic targets from a Drosophila model of Alzheimer's disease. Curr Opin Pharmacol , 4 (5) 513 - 516. 10.1016/j.coph.2004.07.001.

D

Dale, RC; Church, AJ; Surtees, RAH; Lees, AJ; Adcock, JE; Harding, B; ... Giovannoni, G; + view all (2004) Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. BRAIN , 127 21 - 33. 10.1093/brain/awh008.

Davies, N; Beeson, D; Brownlow, S; Hanna, M; (2004) Congenital myasthenic syndrome with episodic apnoea: new mutations and an unusual complication. In: JOURNAL OF NEUROLOGY. (pp. 16 - 16). DR DIETRICH STEINKOPFF VERLAG

de Silva, R; Lashley, T; Revesz, T; Lees, A; Powers, JM; (2004) Detecting tau isoforms in archival cases. ACTA NEUROPATHOL , 107 (2) 181 - 182. 10.1007/s00401-003-0795-x.

de Silva, R; Pittman, AM; Myers, AJ; Wood, NW; Hardy, J; Lees, AJ; (2004) Definition of the tau gene haplotype block that is associated with progressive supranuclear palsy. In: MOVEMENT DISORDERS. (pp. S355 - S355). WILEY-LISS

Dejaegere, T; de Strooper, B; (2004) De secretases als therapeutische doelwitten voor de behandeling van de ziekte van Alzheimer. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie , 66 (1) 29 - 58; discussion 58.

Dejaegere, T; de Strooper, B; (2004) [Secretases as therapeutic targets for the treatment of Alzheimer's disease]. Verh K Acad Geneeskd Belg , 66 (1) 29 - 58.

Depondt, C; Cavalleri, G; Weale, ME; Burly, MW; Cock, H; Shorvon, SD; ... Goldstein, DB; + view all (2004) Common variation in the SCN1A gene is a risk factor for common forms of epilepsy associated with febrile seizures. In: EPILEPSIA. (pp. 120 - 120). BLACKWELL PUBLISHING INC

Depondt, C; Cock, HR; Healy, DG; Burley, MW; Weinshenker, D; Wood, NW; ... Sisodiya, SM; + view all (2004) The -1021C -> T DBH gene variant is not associated with epilepsy or antiepileptic drug response. NEUROLOGY , 63 (8) 1497 - 1499.

Dogu, O; Johnson, J; Hernandez, D; Hanson, M; Hardy, J; Apaydin, H; ... Singleton, A; + view all (2004) A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion. MOVEMENT DISORDERS , 19 (7) 812 - 816. 10.1002/mds.20028.

Dominguez, DI; Hartmann, D; De Strooper, B; (2004) BACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's disease. Neurodegener Dis , 1 (4-5) 168 - 174. 10.1159/000080982.

E

Edwards, MJ; Dale, RC; Church, AJ; Trikouli, E; Quinn, NP; Lees, AJ; ... Bhatia, KP; + view all (2004) Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies. MOVEMENT DISORD , 19 (10) 1190 - 1196. 10.1002/mds.20126.

Edwards, MJ; Trikouli, E; Martino, D; Bozi, M; Dake, RC; Church, AJ; ... Bhatia, KP; + view all (2004) Anti-basal ganglia antibodies in patients with atypical dystonia and tics: A prospective study. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1216 - 1216). B M J PUBLISHING GROUP

Edwards, MJ; Trikouli, E; Martino, D; Bozi, M; Dale, RC; Church, AJ; ... Bhatia, KP; + view all (2004) Anti-basal ganglia antibodies in patients with atypical dystonia and tics - A prospective study. NEUROLOGY , 63 (1) 156 - 158.

Emre, M; Aarsland, D; Albanese, A; Byrne, EJ; Deuschl, G; De Deyn, PP; ... Lane, R; + view all (2004) Rivastigmine for dementia associated with Parkinson's disease. NEW ENGL J MED , 351 (24) 2509 - 2518.

Emre, M.; Aarsland, D.; Albanese, A.; Byrne, E.J.; Deuschl, G.; De Deyn, P.P.; ... Lane, R.; + view all (2004) Rivastigmine for dementia associated with Parkinson's disease. New England Journal of Medicine , 351 (24) pp. 2509-2518. 10.1056/NEJMoa041470. Green open access
file

Esselens, C; Oorschot, V; Baert, V; Raemaekers, T; Spittaels, K; Serneels, L; ... Annaert, W; + view all (2004) Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. J Cell Biol , 166 (7) 1041 - 1054. 10.1083/jcb.200406060.

Evans, AH; Costa, DC; Gacinovic, S; Katzenschlager, R; O'Sullivan, JD; Heales, S; ... Lees, AJ; + view all (2004) L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings. MOVEMENT DISORD , 19 (10) 1232 - 1236. 10.1002/mds.20146.

Evans, AH; Gacinovic, S; Costa, DC; Lees, AJ; (2004) Parkinsonism due to Kernohan notch: Clinical, structural, and functional imaging correlates. NEUROLOGY , 62 (12) 2333 - 2334.

Evans, AH; Katzenschlager, R; Paviour, D; Appel, S; Lawrence, AD; Lees, AJ; (2004) Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1215 - 1215). B M J PUBLISHING GROUP

Evans, AH; Katzenschlager, R; Paviour, D; O'Sullivan, JD; Appel, S; Lawrence, AD; Lees, AJ; (2004) Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome. MOVEMENT DISORD , 19 (4) 397 - 405. 10.1002/mds.20045.

Evans, AH; Lees, AJ; (2004) Dopamine dysregulation syndrome in Parkinson's disease. CURR OPIN NEUROL , 17 (4) 393 - 398. 10.1097/01.wco.0000137528.23126.41.

Evans, W; Fung, HC; Steele, J; Eerola, J; Tienari, P; Pittman, A; ... Hardy, J; + view all (2004) The tau H2 haplotype is almost exclusively Caucasian in origin. NEUROSCI LETT , 369 (3) 183 - 185. 10.1016/j.neulet.2004.05.119.

Everett, CM; Wood, NW; (2004) Trinucleotide repeats and neurodegenerative disease. BRAIN , 127 2385 - 2405. 10.1093/brain/awh278.

Evidente, VGH; Esteban, RP; Hernandez, JL; Natividad, FF; Advincula, J; Gwinn-Hardy, K; ... Singleton, A; + view all (2004) Smell testing is abnormal in 'lubag' or X-linked dystonia-parkinsonism: a pilot study. PARKINSONISM & RELATED DISORDERS , 10 (7) 407 - 410. 10.1016/j.parkreldis.2004.04.011.

F

Fidani, L; Goulas, A; Crook, R; Petersen, RC; Tangalos, E; Kotsis, A; Hardy, J; (2004) An association study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset Alzheimer's disease. NEUROSCIENCE LETTERS , 357 (2) 152 - 154. 10.1016/j.neulet.2003.11.071.

Findley, L; Turunen, H; Apajasalo, M; Lees, A; (2004) New levodopa/carbidopa/entacapone (Stalevo (R)) results in better quality of life for Parkinson's disease patients and saves costs to the society. VALUE IN HEALTH , 7 (6) 788 - 788. 10.1016/S1098-3015(10)66109-8.

Fregni, F; Santos, CM; Marcolin, MA; Pascual-Leone, A; Moriyama, LS; Barbosa, ER; (2004) Repetitive TMS is as effective as fluoxetine in the treatment of depression in Parkinson's disease patients. In: MOVEMENT DISORDERS. (pp. S239 - S240). WILEY-LISS

Furtado, S; Payami, H; Lockhart, PJ; Hanson, M; Nutt, JG; Singleton, AA; ... Stoessl, AJ; + view all (2004) Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). MOVEMENT DISORDERS , 19 (6) 622 - 629. 10.1002/mds.20074.

G

Gerschlager, W; Munchau, A; Katzenschlager, R; Brown, P; Rothwell, JC; Quinn, N; ... Bhatia, KP; + view all (2004) Natural history and syndromic associations of orthostatic tremor: A review of 41 patients. MOVEMENT DISORD , 19 (7) 788 - 795. 10.1002/mds.20132.

Gibb, GM; de, SR; Revesz, T; Lees, AJ; Anderton, BH; Hanger, DP; (2004) Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy. Brain Res Mol Brain Res , 121 (1-2) 95 - 101.

Gibb, GM; de Silva, R; Revesz, T; Lees, AJ; Anderton, BH; Hanger, DP; (2004) Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy. MOL BRAIN RES , 121 (1-2) 95 - 101. 10.1016/j.molbrainres.2003.11.007.

Goncalves, LR; Silveira-Moriyama, L; Heise, CO; Gherpelli, JL; Barbosa, ER; (2004) Cocontractions related to obstetrical brachial plexus palsy treated with botulinum toxin. In: MOVEMENT DISORDERS. (pp. S127 - S127). WILEY-LISS

Grosse, P; Edwards, M; Tijssen, MAJ; Schrag, A; Lees, AJ; Bhatia, KP; Brown, P; (2004) Patterns of EMG-EMG coherence in limb dystonia. MOVEMENT DISORD , 19 (7) 758 - 769. 10.1002/mds.20075.

H

Hanna, MG; (2004) Episodic ataxia and migraine. EUR J NEUROL , 11 341 - 341.

Hanson, M; Honour, M; Singleton, A; Crawley, A; Singleton, A; Hardy, J; Gwinn-Hardy, K; (2004) Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features. JOURNAL OF NEUROLOGY , 251 (11) 1398 - 1401. 10.1007/s00415-004-0552-7.

Hardy, J; (2004) Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo? For. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 31 (11) 1539 - 1540. 10.1007/s00259-004-1676-9.

Hardy, J; (2004) The uncertain anatomy of Alzheimer's disease. NEUROBIOLOGY OF AGING , 25 (6) 719 - 720. 10.1016/j.neurobiolaging.2003.12.012.

Hardy, J; (2004) Toward Alzheimer therapies based on genetic knowledge. ANNUAL REVIEW OF MEDICINE , 55 15 - 25. 10.1146/annurev.med.55.091902.103607.

Hardy, J; Langston, JW; (2004) How many pathways are there to nigral death? ANNALS OF NEUROLOGY , 56 (3) 316 - 318. 10.1002/ana.20257.

Hardy, J; Myers, A; Wavrant-De Vrieze, F; (2004) Problems and Solutions in the Genetic Analysis of Late-Onset Alzheimer's Disease. NEURODEGENERATIVE DISEASES , 1 (4-5) 213 - 217. 10.1159/000080988.

Hébert, SS; Serneels, L; Dejaegere, T; Horré, K; Dabrowski, M; Baert, V; ... De Strooper, B; + view all (2004) Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity. Neurobiol Dis , 17 (2) 260 - 272. 10.1016/j.nbd.2004.08.002.

Healy, DG; Abou-Sleiman, PM; Ahmadi, K; Lees, AJ; Quinn, N; Bhatia, K; ... Wood, NW; + view all (2004) The role of mendelian PD genes in non-mendelian PD: A haplotype tagging approach. In: NEUROLOGY. (pp. A2 - A3).

Healy, DG; Abou-Sleiman, PM; Ahmadi, KR; Muqit, MMK; Bhatia, KP; Quinn, NP; ... Wood, NW; + view all (2004) The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism. ANN NEUROL , 56 (3) 329 - 335.

Healy, DG; Abou-Sleiman, PM; Gibson, JM; Ross, OA; Jain, S; Gandhi, S; ... Lynch, T; + view all (2004) PINK1 (PARK6) associated Parkinson disease in Ireland. NEUROLOGY , 63 (8) 1486 - 1488.

Healy, DG; Abou-Sleiman, PM; Gibson, JM; Ross, OA; Jain, S; Gandhi, S; ... Lynch, T; + view all (2004) PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology , 63 (8) 1486 - 1488.

Healy, DG; Abou-Sleiman, PM; Goldstein, DB; Wood, NW; (2004) Population genetics for target identification. Drug Discov Today Technol , 1 (1) 69 - 74. 10.1016/j.ddtec.2004.08.012.

Healy, DG; Abou-Sleiman, PM; Lees, AJ; Casas, JP; Quinn, N; Bhatia, K; ... Wood, NW; + view all (2004) Tau gene and Parkinson's disease: a case-control study and meta-analysis. J NEUROL NEUROSUR PS , 75 (7) 962 - 965. 10.1136/jnnp.2003.026203.

Healy, DG; Abou-Sleiman, PM; Lees, AJ; Quinn, N; Bhatia, K; Wood, NW; (2004) Tau gene and Parkinson's disease; a case-control study and metaanalysis. In: MOVEMENT DISORDERS. (pp. S195 - S195).

Healy, DG; Abou-Sleiman, PM; Ozawa, T; Lees, AJ; Bhatia, K; Ahmadi, KR; ... Wood, NW; + view all (2004) A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease. ANN NEUROL , 55 (3) 443 - 446.

Healy, DG; Abou-Sleiman, PM; Ozawa, T; Lees, AJ; Bhatia, K; Ahmai, KR; ... Wood, NW; + view all (2004) A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease.(vol 55, 443, 2004). ANNALS OF NEUROLOGY , 56 (2) 311 - 311. 10.1002/ana.20235.

Healy, DG; Abou-Sleiman, PM; Valente, EM; Gilks, WP; Bhatia, K; Quinn, N; ... Wood, NW; + view all (2004) DJ-1 mutations in Parkinson's disease. J Neurol Neurosurg Psychiatry , 75 (1) 144 - 5.

Healy, DG; Abou-Sleiman, PM; Valente, EM; Gilks, WP; Bhatia, K; Quinn, N; ... Wood, NW; + view all (2004) DJ-1 mutations in Parkinson's disease. J NEUROL NEUROSUR PS , 75 (1) 144 - 145.

Healy, DG; Abou-Sleiman, PM; Wood, NW; (2004) Genetic causes of Parkinson's disease: UCHL-1. CELL TISSUE RES , 318 (1) 189 - 194. 10.1007/s00441-004-0917-3.

Healy, DG; Abou-Sleiman, PM; Wood, NW; (2004) PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism. LANCET NEUROL , 3 (11) 652 - 662.

Healy, DG; Wood, NW; (2004) Clinical picture of bilateral vestibular schwannomas, sudden bilateral hearing loss, and aviation. NEUROLOGY , 63 (5) 933 - 933.

Hemsch, MJ; Tuttle, DG; Houlden, HP; Graham, AB; (2004) Measurement of force balance repeatability and reproducibility in the NTF. AIAA Paper 8843 - 8857.

Henley, SM; Warrington, EK; Warner, TT; Stevens, JM; Ashburner, J; Rossor, MN; ... Tabrizi, SJ; + view all (2004) Correlation between patterns of atrophy and psychomotor task performance in early Huntington's disease. In: NEUROBIOLOGY OF AGING. (pp. S462 - S462). ELSEVIER SCIENCE INC

Hope, AD; Lashley, T; Lees, AJ; de Silva, R; (2004) Failure in heat-shock protein expression in response to UBB+1 protein in progressive supranuclear palsy in humans. NEUROSCI LETT , 359 (1-2) 94 - 98. 10.1016/j.neulet.2003.12.0127.

Hope, AD; Lashley, T; Lees, AJ; de Silva, R; (2004) Failure in heat-shock protein expression in response to UBB+1 protein in progressive supranuclear palsy in humans. Neurosci Lett , 359 (1-2) 94 - 98. 10.1016/j.neulet.2003.12.127.

Houlden, H; Blake, J; Reilly, MM; (2004) Hereditary sensory neuropathies. CURR OPIN NEUROL , 17 (5) 569 - 577.

Houlden, H; Girard, M; Cockerell, C; Ingram, D; Wood, NW; Goossens, M; ... Reilly, MM; + view all (2004) Connexin 32 promoter P2 mutations: A mechanism of peripheral nerve dysfunction. ANN NEUROL , 56 (5) 730 - 734. 10.1002/ana.20267.

Houlden, H; King, RHM; Muddle, JR; Warner, TT; Reilly, MM; Orrell, RW; Ginsberg, L; (2004) A novel RAB7 mutation associated with ulcero-mutilating neuropathy. ANN NEUROL , 56 (4) 586 - 590. 10.1002/ana.20281.

Houlden, H; King, RHM; Muddle, JR; Warner, TT; Reilly, MM; Orrell, RW; Ginsberg, L; (2004) Ulcero-mutilating neuropathy: Clinical, pathological and molecular genetic study of a family with a novel RAB7 mutation. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1228 - 1228). B M J PUBLISHING GROUP

Houlden, H.; Girard, M.; Cockerell, C.; Ingram, D.; Wood, N.W.; Goossens, M.; ... Reilly, M.M.; + view all (2004) Connexin 32 promoter P2 mutations: a mechanism of peripheral nerve dysfunction. Annals of Neurology , 56 (5) pp. 730-734. 10.1002/ana.20267.

Houlden, H.; King, R.H.M.; Muddle, J.R.; Warner, T.T.; Reilly, M.M.; Orrell, R.W.; Ginsberg, L.; (2004) A novel RAB7 mutation associated with ulcero-mutilating neuropathy. Annals of Neurology , 56 (4) pp. 586-590. 10.1002/ana.20281.

I

Imbrici, P; Jaffe, SL; Eunson, LH; Davies, NP; Herd, C; Robertson, R; ... Hanna, MG; + view all (2004) Dysfunction of the brain calcium channel Ca(V)2.1 in absence epilepsy and episodic ataxia. BRAIN , 127 2682 - 2692. 10.1093/brain/awh301.

Imbrici, P.; Jaffe, S.L.; Eunson, L.H.; Davies, N.P.; Herd, C.; Robertson, R.; ... Hanna, M.G.; + view all (2004) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain , 127 (12) pp. 2682-2692. 10.1093/brain/awh301.

Isenberg, DA; Allen, E; Farewell, V; Ehrenstein, MR; Hanna, MG; Lundberg, IE; ... Int Myositis Clinical Studies Grp,; + view all (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. RHEUMATOLOGY , 43 (1) 49 - 54. 10.1093/rheumatology/keg427.

J

Johansson, A; Katzov, H; Zetterberg, H; Feuk, L; Johansson, B; Bogdanovic, N; ... Prince, JA; + view all (2004) Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease. Hum Genet , 114 (6) 581 - 587. 10.1007/s00439-004-1107-9.

Johnson, J; Hague, SM; Hanson, M; Gibson, A; Wilson, KE; Evans, EW; ... Singleton, AB; + view all (2004) SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. NEUROLOGY , 63 (3) 554 - 556.

Johnson, J; Ostojic, J; Lannfelt, L; Glaser, A; Basun, H; Rogaeva, E; ... Singleton, A; + view all (2004) No evidence for tau duplications in frontal temporal dementia families showing genetic linkage to the tau locus in which tau mutations have not been found. NEUROSCIENCE LETTERS , 363 (2) 99 - 101. 10.1016/j.neulet.2004.03.070.

Josephs, KA; Holton, JL; Rossor, MN; Godbolt, AK; Ozawa, T; Strand, K; ... Revesz, T; + view all (2004) Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. NEUROPATH APPL NEURO , 30 (4) 369 - 373. 10.1111/j.1365-2990.2004.00545.x.

Josephs, KA; Holton, JL; Rossor, MN; Godbolt, AK; Ozawa, T; Strand, K; ... Revesz, T; + view all (2004) Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. NEUROPATH APPL NEURO , 30 (4) 369 - 373. 10.1111/j.1365-2990.2004.00545.x.

K

Katzenschlager, R; Evans, A; Manson, A; Patsalos, P; Ratnaraj, N; Lees, AJ; (2004) Mucuna pruriens in Parkinson's disease: A double-blind clinical and pharmacological study. In: MOVEMENT DISORDERS. (pp. S249 - S249). WILEY-LISS

Katzenschlager, R; Evans, A; Manson, A; Patsalos, PN; Ratnaraj, N; Watt, H; ... Lees, AJ; + view all (2004) Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J NEUROL NEUROSUR PS , 75 (12) 1672 - 1677. 10.1136/jnnp.2003.028761.

Katzenschlager, R; Head, J; Schrag, A; Lees, AJ; PDRGUK,; (2004) Final, 14-year follow-up of the randomized, controlled PDRG trial comparing three treatments in de novo Parkinson's disease. EUR J NEUROL , 11 103 - 103.

Katzenschlager, R; Lees, AJ; (2004) Olfaction and Parkinson's syndromes: its role in differential diagnosis. CURR OPIN NEUROL , 17 (4) 417 - 423. 10.1097/01.wco.0000137531.76491.c2.

Katzenschlager, R; Manson, AJ; Evans, A; Watt, H; Lees, AJ; (2004) Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study. J NEUROL NEUROSUR PS , 75 (2) 295 - 297.

Katzenschlager, R; Zijlmans, J; Evans, A; Watt, H; Lees, AJ; (2004) Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. J NEUROL NEUROSUR PS , 75 (12) 1749 - 1752. 10.1136/jnnp.2003.035287.

Khan, NL; Katzenschlager, R; Watt, H; Bhatia, KP; Wood, NW; Quinn, N; Lees, AJ; (2004) Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. NEUROLOGY , 62 (7) 1224 - 1226.

Kinali, M; Jungbluth, H; Eunson, LH; Sewry, CA; Manzur, AY; Mercuri, E; ... Muntoni, F; + view all (2004) Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia. NEUROMUSCULAR DISORD , 14 (10) 689 - 693. 10.1016/j.nmd.2004.06.007.

Kingsbury, AE; Daniel, SE; Sangha, H; Eisen, S; Lees, AJ; Foster, OJF; (2004) Alteration in alpha-synuclein mRNA expression in Parkinson's disease. MOVEMENT DISORD , 19 (2) 162 - 170. 10.1002/mds.10683.

Kuo, L; An, SF; Groves, MJ; Lee, C; Scaravilli, F; (2004) Gene expression profile in rat dorsal root ganglion (DRG) following sciatic nerve transection and systemic neurotrophin-3 (NT-3) administration. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. (pp. 516 - 516). AMER ASSN NEUROPATHOLOGISTS INC

L

Lang, AE; Lees, AJ; (2004) Farewell from the outgoing Editors. Movement Disorders , 19 (1) 2 - 2. 10.1002/mds.20026.

Lashley, T; Holton, JL; Frangione, B; Bandopadhyay, R; Ghiso, J; Rostagno, A; Revesz, T; (2004) The possible origin of the amyloid peptides in the BRI2 gene-related dementias. In: NEUROBIOLOGY OF AGING. (pp. S171 - S171). ELSEVIER SCIENCE INC

Lee, C; Scaravilli, F; Kuo, L; Wang, C; An, SF; (2004) Accumulation of prion protein in the peripheral nervous system of human forms of the disease: An immunohistochemical study. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. (pp. 515 - 515). AMER ASSN NEUROPATHOLOGISTS INC

Lee, MJ; Stephenson, D; Groves, M; Sweeney, M; Davis, M; An, SF; ... Reilly, M; + view all (2004) Sensory deprivation is associated with a mutation in the rat chaperonin delta subunit. In: GENETICAL RESEARCH. (pp. 120 - 120). CAMBRIDGE UNIV PRESS

Lees, A; Gershanik, O; Blin, O; Behari, M; Otero, E; Ferreira, J; ... Rascol, O; + view all (2004) Piribedil efficacy in monotherapy (150 to 300 mg/day) in de novo parkinsonian patients: A 6-month intermediate analysis of the 2-year Parkinson-Regain study. In: NEUROLOGY. (pp. A399 - A399).

Lees, A; Koe, MR; (2004) Fourth Progressive Supranuclear Palsy (PSP-Europe) International Medical Workshop - Abstracts. MOVEMENT DISORD , 19 (3) 356 - 357. 10.1002/mds.20016.

Lees, AJ; (2004) Atypical parkinsonism. In: MOVEMENT DISORDERS. (pp. S10 - S10).

Lees, AJ; (2004) Controversy in treatment of Parkinson's disease. In: JOURNAL OF NEUROLOGY. (pp. 3 - 4).

Lees, AJ; (2004) Non-motor manifestations of \Parkinson's disease. EUR J NEUROL , 11 348 - 348.

Li, C; Varsani, H; Maillard, S; Jones, R; Holton, J; Woo, P; Wedderburn, LR; (2004) Do histological features parallel clinical severity in Juvenile Dermatomyositis: Proposal of a novel scoring system. In: Clin.Exp.Rheumatol. (pp. 529 - 529).

Li, CKC; Varsani, H; Holton, JL; Gao, B; Woo, P; Wedderburn, LR; Juvenile Dermatomyositis Res Grp,; (2004) MHC class I overexpression on muscles in early juvenile derma-tomyositis. J RHEUMATOL , 31 (3) 605 - 609.

Li, Y; Nowotny, P; Holmans, P; Smemo, S; Kauwe, JSK; Hinrichs, AL; ... Grupe, A; + view all (2004) Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 101 (44) 15688 - 15693. 10.1073/pnas.0403535101.

Li, YH; Tacey, K; Doil, L; van Luchene, R; Garcia, V; Rowland, C; ... Grupe, A; + view all (2004) Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. NEUROSCIENCE LETTERS , 366 (3) 268 - 271. 10.1016/j.neulet.2004.05.047.

Liolitsa, D; Rahman, S; Bentos, S; Carr, LJ; Hanna, MG; (2004) Is the Mitochondrial Complex 1 ND5 Gene a hot spot for MELAS causing mutations? Annals of Neurology (53) 128 - 132.

Lomas, DA; Belorgey, D; Mallya, M; Onda, M; Kinghorn, KJ; Sharp, LK; ... Miranda, E; + view all (2004) Polymerisation underlies alpha1-antitrypsin deficiency, dementia and other serpinopathies. Front Biosci , 9 2873 - 2891.

M

MacCormac, LP; Muqit, MMK; Faulkes, DJ; Wood, NW; Latchman, DS; (2004) Reduction in endogenous parkin levels renders glial cells sensitive to both caspase-dependent and caspase-independent cell death. EUR J NEUROSCI , 20 (8) 2038 - 2048. 10.1111/j.1460-9568.2004.03659.x.

Mantuano, E; Veneziano, L; Spadaro, M; Giunti, P; Guida, S; Leggio, MG; ... Frontali, M; + view all (2004) Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit Ca(v)2.1 causing episodic ataxia 2. J MED GENET , 41 (6) , Article e82. 10.1136/jmg.2003.015396.

Marjaux, E; De Strooper, B; (2004) γ-secretase inhibitors: Still in the running as Alzheimer's therapeutics. Drug Discovery Today: Therapeutic Strategies , 1 (1) 1 - 6. 10.1016/j.ddstr.2004.05.001.

Marjaux, E; Hartmann, D; De Strooper, B; (2004) Presenilins in memory, Alzheimer's disease, and therapy. Neuron , 42 (2) 189 - 192.

Martinez, M; Brice, A; Vaughan, JR; Zimprich, A; Breteler, MMB; Meco, G; ... European Consortium Genetic Susc,; + view all (2004) Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease. J MED GENET , 41 (12) 900 - 907. 10.1136/jmg.2004.022632.

McCaddon, A; Blennow, K; Hudson, P; Hughes, A; Barber, J; Gray, R; ... Regland, B; + view all (2004) Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease. Dement Geriatr Cogn Disord , 17 (3) 215 - 221. 10.1159/000076359.

McKenzie, M; Liolitsa, D; Hanna, MG; (2004) Mitochondrial disease: Mutations and mechanisms. NEUROCHEM RES , 29 (3) 589 - 600.

McKenzie, M; Liolitsa, D; Sisodiya, S; Wood, N; Duchen, M; Hanna, M; (2004) A homoplasmic ND5 mutation associated with MELAS: mitochondria as ATP consumers? In: BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS. (pp. 41 - 41). ELSEVIER SCIENCE BV

McNeill, A; Cano, SJ; Warner, TT; (2004) Clinical diagnosis of cervical dystonia. European Journal of General Practice , 10 (2) 73 - 74.

Miller, RF; Isaacson, PG; Hall-Craggs, M; Lucas, S; Gray, F; Scaravilli, F; An, SF; (2004) Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. ACTA NEUROPATHOL , 108 (1) 17 - 23. 10.1007/s00401-004-0852-0.

Misbahuddin, A; Placzek, MR; Warner, TT; (2004) Focal dystonia is associated with a polymorphism of the dopamine D5 receptor gene. Advances in Neurology , 94 143 - 146.

Morris, HR; Steele, JC; Crook, R; Wavrant-De Vrieze, F; Onstead-Cardinale, L; Gwinn-Hardy, K; ... Perez-Tur, J; + view all (2004) Genome-wide analysis of the Parkinsonism-dementia complex of Guam. ARCH NEUROL-CHICAGO , 61 (12) 1889 - 1897.

Muqit, MMK; Davidson, SM; Smith, MDP; MacCormac, LP; Kahns, S; Jensen, PH; ... Latchman, DS; + view all (2004) Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. HUM MOL GENET , 13 (1) 117 - 135. 10.1093/hmg/ddh012.

Murphy, RT; Mogensen, J; Bahl, A; Kobu, T; Holton, J; Elliott, PM; ... McKenna, WJ; + view all (2004) AMP kinase disease in hypertrophic cardiomyopathy: Evidence for a multisystem storage disorder. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. (pp. 166A - 166A).

Myers, AJ; Marshall, H; Holmans, P; Compton, D; Crook, RJP; Mander, AP; ... Goate, A; + view all (2004) Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS , 124B (1) 29 - 37. 10.1002/ajmg.b.20036.

Myers, AJ; Pittman, A; Duckworth, J; Fung, P; Evans, J; Evans, W; ... Hardy, JA; + view all (2004) Investigation of the microtubule associated protein tau locus. In: AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS. (pp. 16 - 16). WILEY-LISS

N

Nagano, O; Murakami, D; Hartmann, D; De Strooper, B; Saftig, P; Iwatsubo, T; ... Saya, H; + view all (2004) Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol , 165 (6) 893 - 902. 10.1083/jcb.200310024.

Nichols, AM; Pan, Y; Herreman, A; Hadland, BK; De Strooper, B; Kopan, R; Huppert, SS; (2004) Notch pathway is dispensable for adipocyte specification. Genesis , 40 (1) 40 - 44. 10.1002/gene.20061.

Nirmalananthan, N; Holton, JL; Hanna, MG; (2004) Is it really myositis? A consideration of the differential diagnosis. CURR OPIN RHEUMATOL , 16 (6) 684 - 691.

O

Olasode, BJ; Muthane, U; Hendersen, J; Daniels, SE; Lees, AJ; (2004) Melanized nigral neurons in caucasians and Africans. In: NEUROBIOLOGY OF AGING. (pp. S482 - S482).

Osaki, Y; Ben-Shlomo, Y; Colosimo, C; Wenning, GK; Lees, AJ; Quinn, NP; (2004) The accuracy of clinical diagnosis of progressive supranuclear palsy: Applications with "grey"cases and true negative cases. In: MOVEMENT DISORDERS. (pp. S336 - S336).

Osaki, Y; Ben-Shlomo, Y; Lees, AJ; Daniel, SE; Colosimo, C; Wenning, GK; Quinn, N; (2004) Accuracy of clinical diagnosis of progressive supranuclear palsy. MOVEMENT DISORD , 19 (2) 181 - 189. 10.1002/mds.10680.

Osaki, Y; Ben-Shlomo, Y; Wenning, GK; Lees, AJ; Mathias, CJ; Quinn, NP; (2004) The accuracy of clinical diagnosis of multiple system atrophy: Applications with "grey"cases and true negative cases. In: MOVEMENT DISORDERS. (pp. S336 - S336).

Ozawa, T; Paviour, D; Quinn, NP; Josephs, KA; Sangha, H; Kilford, L; ... Revesz, T; + view all (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. BRAIN , 127 2657 - 2671. 10.1093/brain/awh303.

Ozawa, T; Revesz, T; Holton, JL; Quinn, N; Lees, AJ; Josephs, KA; (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: Clinicopathological correlations. In: MOVEMENT DISORDERS. (pp. S335 - S335). WILEY-LISS

Ozawa, T.; Paviour, D.; Quinn, N.P.; Josephs, K.A.; Sangha, D.; Kilford, L.; ... Revesz, T.; + view all (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain , 127 (12) pp. 2657-2671. 10.1093/brain/awh303.

P

Page, R.A.; Davie, C.A.; MacManus, D.; Miszkiel, K.A.; Walshe, J.M.; Miller, D.H.; ... Schapira, A.H.V.; + view all (2004) Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease. Neurology , 63 (4) pp. 638-643.

Page, RA; Davie, CA; MacManus, D; Miszkiel, KA; Walshe, JM; Miller, DH; ... Schapira, AHV; + view all (2004) Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease. NEUROLOGY , 63 (4) 638 - 643.

Paisan-Ruiz, C; Jain, S; Evans, EW; Gilks, WP; Simon, J; van der Brug, M; ... Singleton, AB; + view all (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. NEURON , 44 (4) 595 - 600.

Patani, R; (2004) Living with multiple sclerosis in the community: A case report. North and West London Journal of General Practice , 10 (1) 5 - 9.

Pavese, N; Evans, AH; Tai, YF; Appel, S; Doder, M; Lawrence, AH; ... Piccini, P; + view all (2004) Compulsive use of dopamine replacement therapy in Parkinson's disease: In vivo evidence of dopaminergic reward system dysregulation with PET. In: NEUROLOGY. (pp. A431 - A431).

Paviour, DC; Lees, AJ; Josephs, KA; Ozawa, T; Ganguly, M; Strand, C; ... Holton, JL; + view all (2004) Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. BRAIN , 127 2441 - 2451. 10.1093/brain/awh265.

Paviour, DC; Lees, AJ; Josephs, KA; Ozawa, T; Ganguly, M; Strand, C; ... Holton, JL; + view all (2004) Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain , 127 (Pt 11) 2441 - 2451. 10.1093/brain/awh265.

Paviour, DC; Price, SL; Stevens, J; Lees, AJ; Fox, NC; (2004) Superior cerebellar peduncle volume measurement on MRI differentiates progressive supranuclear palsy (PSP) from multiple system atrophy (MSA), Parkinson's disease (PD) and controls. In: MOVEMENT DISORDERS. (pp. S368 - S369).

Paviour, DC; Price, SL; Stevens, JM; Rossor, MN; Lees, AJ; Fox, NC; (2004) Differences in atrophy on MRI and voxel-based morphometry in progressive supranuclear palsy (PSP) and Parkinson's disease (PD). In: NEUROLOGY. (pp. A509 - A509).

Paviour, DC; Schott, JM; Stevens, JM; Revesz, T; Holton, JL; Rossor, MN; ... Fox, NC; + view all (2004) Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy. J NEUROL NEUROSUR PS , 75 (12) 1772 - 1775. 10.1136/jnnp.2003.033472.

Paviour, DC; Surtees, RAH; Lees, AJ; (2004) Diagnostic considerations in juvenile parkinsonism. MOVEMENT DISORD , 19 (2) 123 - 135. 10.1002/mds.10644.

Perret, D; Guillet, C; Elson, G; Froger, J; Plun-Favreau, H; Rousseau, F; ... Gascan, H; + view all (2004) Two different contact sites are recruited by cardiotrophin-like cytokine (CLC) to generate the CLC/CLF and CLC/sCNTFR alpha composite cytokines. J BIOL CHEM , 279 (42) 43961 - 43970. 10.1074/jbc.M407686200. Gold open access

Petrucelli, L; Dickson, D; Kehoe, K; Taylor, J; Snyder, H; Grover, A; ... Hutton, M; + view all (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. HUMAN MOLECULAR GENETICS , 13 (7) 703 - 714. 10.1093/hmg/ddh083.

Pickering-Brown, S; Baker, M; Bird, T; Trojanowski, J; Lee, V; Morris, H; ... Hutton, M; + view all (2004) Evidence of a founder effect in families with frontotemporal dementia that Harbor the tau+16 splice mutation. AM J MED GENET B , 125B (1) 79 - 82. 10.1002/ajmg.b.20083.

Pickering-Brown, S; Baker, M; Bird, T; Trojanowski, J; Lee, V; Morris, H; ... Hutton, M; + view all (2004) Evidence of a founder effect in families with frontotemporal dementia that Harbor the tau+16 splice mutation. AM J MED GENET B , 125B (1) 79 - 82. 10.1002/ajmg.b.20083.

Pickering-Brown, SM; Baker, M; Nonaka, T; Ikeda, K; Sharma, S; Mackenzie, J; ... Mann, DMA; + view all (2004) Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene. BRAIN , 127 1415 - 1426. 10.1093/brain/awh147.

Pifl, C; Khorchide, M; Kattinger, A; Reither, H; Hardy, J; Hornykiewicz, O; (2004) alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter. NEUROSCIENCE LETTERS , 354 (1) 34 - 37. 10.1016/j.neulet.2003.09.064.

Pittman, A.M.; Myers, A.J.; Duckworth, J.; Bryden, L.; Hanson, M.; Abou-Sleiman, P.; ... de Silva, R.; + view all (2004) The structure of the tau haplotype in controls and in progressive supranuclear palsy. Human Molecular Genetics , 13 (12) pp. 1267-1274. 10.1093/hmg/ddh138.

Pittman, AM; Myers, AJ; Duckworth, J; Bryden, L; Hanson, M; Abou-Sleiman, P; ... de Silva, R; + view all (2004) The structure of the tau haplotype in controls and in progressive supranuclear palsy. HUM MOL GENET , 13 (12) 1267 - 1274. 10.1093/hmg/ddh138.

Plant, GT; Ghiso, J; Holton, JL; Frangione, B; Revesz, T; (2004) Familial and sporadic cerebral amyloid angiopathies associated with dementia and the BRI dementias. In: Esiri, MM and Lee, MY and Trojanowski, JQ, (eds.) The neuropathology of dementia. (330 - 352). Cambridge University Press: Cambridge.

Price, S; Paviour, D; Scahill, R; Stevens, J; Rossor, M; Lees, A; Fox, N; (2004) Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. NEUROIMAGE , 23 (2) 663 - 669. 10.1016/j.neuroimage.2004.06.013.

Price, SL; Paviour, DC; Scahill, RI; Stevens, JM; Lees, AJ; Fox, NC; (2004) VBM as a tool to identify regions which may aid differential diagnosis of PSP, PD and MSA using MRI. In: MOVEMENT DISORDERS. (pp. S377 - S377). WILEY-LISS

Prince, JA; Zetterberg, H; Andreasen, N; Marcusson, J; Blennow, K; (2004) APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology , 62 (11) 2116 - 2118.

Prince, JA; Zetterberg, H; Blennow, K; Andreasen, N; Marcusson, J; (2004) A-POE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42. Neurology , 62 (11) 2116 - 2118.

Proukakis, C; Taanman, JW; Cooper, JM; Warner, TT; (2004) Cellular studies of spastin, the protein commonly mutated in autosomal dominant hereditary spastic paraplegia (SPG4). In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 521 - 521). B M J PUBLISHING GROUP

R

Rascol, O; Gershanik, O; Blin, O; Ferreira, J; Bodjarian, N; Lees, A; (2004) Piribedil efficacy in monotherapy (150 to 300 mg/day) in de novo parkinsonian patients: A 6-month planned intermediate of the 2-year Parkinson-regain study. In: MOVEMENT DISORDERS. (pp. S215 - S215).

Reiman, EM; Chen, KW; Alexander, GE; Caselli, RJ; Bandy, D; Osborne, D; ... Hardy, J; + view all (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 101 (1) 284 - 289. 10.1073/pnas.2635903100.

Roedling, S; Pearl, D; Manji, H; Hanna, MG; Holton, JL; Miller, RF; (2004) Unusual muscle disease in HIV infected patients. SEX TRANSM INFECT , 80 (4) 315 - 317. 10.1136/sti.2003.008474.

Rogaeva, E; Johnson, J; Lang, AE; Gulick, C; Gwinn-Hardy, K; Kawarai, T; ... Singleton, AB; + view all (2004) Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. ARCHIVES OF NEUROLOGY , 61 (12) 1898 - 1904. 10.1001/archneur.61.12.1898.

Rosenkranz, K; Williamom, A; Butler, K; Cordivari, C; Lees, A; Rothwell, JC; (2004) Differences in the disordered sensorimotor organisation of the hand in musician's dystonia and writer's cramp: Clue for different pathophysiology? In: MOVEMENT DISORDERS. (pp. S108 - S108). WILEY-LISS

Rossor, MN; Hanna, MG; (2004) New year, new editorial team. J NEUROL NEUROSUR PS , 75 (1) 1 - 1.

Rostagno, A; Zhao, ZH; Ng, D; Lashley, T; Holton, J; Frangione, B; ... Ghiso, J; + view all (2004) Familial British and Danish dementias: BRI2 gene and protein expression by human cerebral cells. In: NEUROBIOLOGY OF AGING. (pp. S170 - S171). ELSEVIER SCIENCE INC

S

Santana, I; Guerreiro, R; Paiva, A; Sarmento, A; Santiago, B; Barbosa, V; Oliveira, C; (2004) Inflammation in mild cognitive impairment and mild Alzheimer's disease. In: NEUROBIOLOGY OF AGING. (pp. S534 - S534). ELSEVIER SCIENCE INC

Scherfler, C; Khan, NL; Pavese, N; Eunson, L; Graham, E; Lees, AJ; ... Piccini, PP; + view all (2004) Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. BRAIN , 127 1332 - 1342. 10.1093/brain/awh150.

Schmierer, K.; Scaravilli, F.; Altmann, D.R.; Barker, G.J.; Miller, D.H.; (2004) Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Annals of Neurology , 56 (3) pp. 407-415. 10.1002/ana.20202.

Schott, JM; Lees, AJ; Rossor, MN; (2004) Dementia in dementia with Lewy bodies may not be attributable to Alzheimer pathology. ANN NEUROL , 56 (4) 604 - 604. 10.1002/ana.20271.

Serra-Mestres, J; Ring, HA; Costa, DC; Gacinovic, S; Walker, Z; Lees, AJ; ... Trimble, MR; + view all (2004) Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Acta Psychiatr Scand , 109 (2) 140 - 146.

Serra-Mestres, J; Ring, HA; Costa, DC; Gacinovic, S; Walker, Z; Lees, AJ; ... Trimble, MR; + view all (2004) Dopamine transporter binding in Gilles de la Tourette syndrome: a [I-123]FP-CIT/SPECT study. ACTA PSYCHIAT SCAND , 109 (2) 140 - 146.

Silveira-Moriyama, L; Goncalves, LR; Maria-Santos, A; Chien, HF; Barbosa, ER; (2004) Long-term efficacy of botulinum toxin A in the treatment of blepharospasm over a 10-year period. In: MOVEMENT DISORDERS. (pp. S98 - S99). WILEY-LISS

Silveira-Moriyama, L; Moriyama, TS; Gabbi, TVB; Ranvaud, R; Barbosa, ER; (2004) Chediak-Higashi syndrome with parkinsonism. MOVEMENT DISORD , 19 (4) 472 - 475. 10.1002/mds.10677.

Singleton, A; Gwinn-Hardy, K; Sharabi, Y; Li, ST; Holmes, C; Dendi, R; ... Goldstein, DS; + view all (2004) Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. BRAIN , 127 768 - 772. 10.1093/brain/awh081.

Singleton, A; Myers, A; Hardy, J; (2004) The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. HUMAN MOLECULAR GENETICS , 13 R123 - R126. 10.1093/hmg/ddh093.

Sinha, KK; Worth, PF; Jha, DK; Sinha, S; Stinton, VJ; Davis, MB; ... Bhatia, KP; + view all (2004) Autosomal dominant cerebellar ataxia: SCA2 is the most frequent mutation in eastern India. J NEUROL NEUROSUR PS , 75 (3) 448 - 452. 10.1136/jnnp.2002.004895.

Smith, CCT; Stanyer, L; Betteridge, DJ; (2004) Soluble beta-amyloid (A beta) 40 causes attenuation or potentiation of noradrenaline-induced vasoconstriction in rats depending upon the concentration employed. NEUROSCI LETT , 367 (1) 129 - 132. 10.1016/j.neulet.2004.05.094.

Soranzo, N; Cavalleri, GL; Weale, ME; Wood, NW; Depondt, C; Marguerie, R; ... Goldstein, DB; + view all (2004) Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. GENOME RES , 14 (7) 1333 - 1344.

Spadaro, M; Ursu, S; Lehmann-Horn, F; Liana, V; Giovanni, A; Paola, G; ... Jurkat-Rott, K; + view all (2004) A G301R Na+/K+-ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. NEUROGENETICS , 5 (3) 177 - 185. 10.1007/s10048-004-0183-2.

Stanyer, L; Betteridge, DJ; Smith, CCT; (2004) Exaggerated polymerisation of beta-amyloid 40 stimulated by plasma lipoproteins results in fibrillar A beta preparations that are ineffective in promoting ADP-induced platelet aggregation. BBA-GEN SUBJECTS , 1674 (3) 305 - 311. 10.1016/j.bbagen.2004.07.005.

Stanyer, L; Betteridge, DJ; Smith, CCT; (2004) Potentiation of beta-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivity. BBA-GEN SUBJECTS , 1670 (2) 147 - 155. 10.1016/j.bbagen.2003.11.005.

Strandhagen, E; Zetterberg, H; Aires, N; Palmér, M; Rymo, L; Blennow, K; ... Thelle, DS; + view all (2004) The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study. Int J Mol Med , 13 (6) 811 - 815.

Strandhagen, E; Zetterberg, H; Aires, N; Palmér, M; Rymo, L; Blennow, K; Thelle, DS; (2004) The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee. Lipids Health Dis , 3 26 - ?. 10.1186/1476-511X-3-26.

Sumner, P; Nachev, P; Vora, N; Husain, M; Kennard, C; (2004) Distinct cortical and collicular mechanisms of inhibition of return - Revealed with S cone stimuli. CURR BIOL , 14 (24) 2259 - 2263. 10.1016/j.cub.2004.12.021.

T

Tabrizi, SJ; Beck, JA; Poulter, M; Campbell, T; Uphill, JB; Adamson, G; ... Collinge, J; + view all (2004) Somatic mosaicism in sporadic early-onset Alzheimer's disease. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1216 - 1216). B M J PUBLISHING GROUP

Teixeira, MJ; Maria-Santos, A; Fonoff, ET; Silveira-Moriyama, L; Barbosa, ER; Marchese, AT; (2004) Percutaneous radiofrequency facial nerve neurectomy, selective facial neurectomy, blepharoplasty and elevation of eyebrows for treatment of facial dyskinesias. In: MOVEMENT DISORDERS. (pp. S320 - S320). WILEY-LISS

Togo, T; Akiyama, H; Iseki, E; Uchikado, H; Kondo, H; Ikeda, K; ... Kosaka, K; + view all (2004) Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions. ACTA NEUROPATHOL , 107 (6) 504 - 508. 10.1007/s00401-004-0842-2.

Tournoy, J; Bossuyt, X; Snellinx, A; Regent, M; Garmyn, M; Serneels, L; ... Hartmann, D; + view all (2004) Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice. Hum Mol Genet , 13 (13) 1321 - 1331. 10.1093/hmg/ddh151.

V

Valente, E.M.; Abou-Sleiman, P.M.; Caputo, V.; Muqit, M.M.K.; Harvey, K.; Gispert, S.; ... Wood, N.W.; + view all (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science , 304 (5674) pp. 1158-1160. 10.1126/science.1096284.

Valente, E.M.; Abou-Sleiman, P.M.; Caputo, V.; Muqit, M.M.K.; Harvey, K.; Gispert, S.; ... Wood, N.W.; + view all (2004) Hereditary early-onset parkinson's disease caused by mutations in PINK1. Science , 304 (5674) pp. 1158-1160. 10.1126/science.1096284.

Valente, EM; Abou-Sleiman, PM; Caputo, V; Muqit, MMK; Gispert, S; Ali, Z; ... Wood, NW; + view all (2004) PARK6 linked Parkinson's disease is caused by mutations in a mitochondrial protein kinase. JOURNAL OF NEUROLOGY , 251 50 - 50.

Valente, EM; Abou-Sleiman, PM; Caputo, V; Muqit, MMK; Harvey, K; Gispert, S; ... Wood, NW; + view all (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. SCIENCE , 304 (5674) 1158 - 1160. 10.1126/science.1096284.

Valente, EM; Abou-Sleiman, PM; Caputo, V; Muqit, MMK; Harvey, K; Gispert, S; ... Wood, NW; + view all (2004) Identification of PINK1, the first mitochondrial gene causing Parkinson's disease. EUR J NEUROL , 11 366 - 367.

Vandrovcová, J; Stekrová, J; Kebrdlová, V; Kohoutová, M; (2004) Molecular analysis of the APC and MYH genes in Czech families affected by FAP or multiple adenomas: 13 novel mutations. Hum Mutat , 23 (4) 397 - ?. 10.1002/humu.9224.

W

Warner, TT; Patel, H; Proukakis, C; Reed, JA; McKie, L; Wills, A; ... Crosby, AH; + view all (2004) A clinical, genetic and candidate gene study of Silver syndrome, a complicated form of hereditary spastic paraplegia. J NEUROL , 251 (9) 1068 - 1074. 10.1007/s00415-004-0401-8.

Warren, NM; Piggott, MA; Greally, E; Lake, M; Kilford, L; Lees, AJ; Burn, DJ; (2004) Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1227 - 1227).

Wenning, GK; Seppi, K; Diem, A; Poewe, W; Tison, F; Yekhlef, F; ... Bergquist, J; + view all (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Movement Disorders , 19 (12) 1391 - 1402. 10.1002/mds.20255.

Wiley, J; Lynch, T; Lincoln, S; Skipper, L; Hulihan, M; Gosal, D; ... Farrer, MJ; + view all (2004) Parkinson's disease in Ireland: Clinical presentation and genetic heterogeneity in patients with parkin mutations. MOVEMENT DISORDERS , 19 (6) 677 - 681. 10.1002/mds.10703.

Wilkinson, P.A.; Crosby, A.H.; Turner, C.; Bradley, L.J.; Ginsberg, L.; Wood, N.W.; ... Warner, T.T.; + view all (2004) A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain , 127 (5) pp. 973-980. 10.1093/brain/awh125.

Wilkinson, PA; Crosby, AH; Turner, C; Bradley, LJ; Ginsberg, L; Wood, NW; ... Warner, TT; + view all (2004) A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. BRAIN , 127 973 - 980. 10.1093/brain/awh125.

Williams, DR; Paviour, DC; Watt, HC; Lees, AJ; (2004) Characteristics of two distinct clinical phenotypes observed in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-Parkinsonism. In: MOVEMENT DISORDERS. (pp. S328 - S329).

Wilquet, V; De Strooper, B; (2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol , 14 (5) 582 - 588. 10.1016/j.conb.2004.08.001.

Winblad, B; Palmer, K; Kivipelto, M; Jelic, V; Fratiglioni, L; Wahlund, LO; ... Petersen, RC; + view all (2004) Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. In: JOURNAL OF INTERNAL MEDICINE. (pp. 240 - 246).

Windpassinger, C; Auer-Grumbach, M; Irobi, J; Patel, H; Petek, E; Horl, G; ... Wagner, K; + view all (2004) Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. NAT GENET , 36 (3) 271 - 276. 10.1038/ng1313.

Wood, N; Muqit, M; (2004) Identification of PINK1 (PARK6), the first mitochondrial gene causing Parkinson's disease. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1220 - 1220). B M J PUBLISHING GROUP

Wrigley, JD; Nunn, EJ; Nyabi, O; Clarke, EE; Hunt, P; Nadin, A; ... Beher, D; + view all (2004) Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor binding. J Neurochem , 90 (6) 1312 - 1320. 10.1111/j.1471-4159.2004.02596.x.

Z

Zetterberg, H; (2004) Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol , 2 7 - ?. 10.1186/1477-7827-2-7.

Zetterberg, H; Andreasen, N; Blennow, K; (2004) Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease. Neurosci Lett , 367 (2) 194 - 196. 10.1016/j.neulet.2004.06.001.

Zetterberg, H; Blennow, K; (2004) Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results. Neurol Sci , 25 (5) 301 - 302. 10.1007/s10072-004-0358-5.

Zetterberg, H; Boreström, C; Nilsson, T; Rymo, L; (2004) Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter. Int J Oncol , 25 (3) 693 - 696.

Zetterberg, H; Nilsson-Ehle, H; (2004) False-negative result in the detection of an IgM monoclonal protein by capillary zone electrophoresis. Clin Chem , 50 (10) 1878 - 1880. 10.1373/clinchem.2004.038372.

Zetterberg, M; Zetterberg, H; Palmér, M; Rymo, L; Blennow, K; Tasa, G; ... Höglund, K; + view all (2004) Apolipoprotein E polymorphism in patients with cataract. Br J Ophthalmol , 88 (5) 716 - 718.

Zijlmans, JC; Katzenschlager, R; Daniel, SE; Lees, AJ; (2004) The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry , 75 (4) 545 - 547.

Zijlmans, JCM; Daniel, SE; Hughes, AJ; Revesz, T; Lees, AJ; (2004) Clinicopathological including investigation of vascular parkinsonism, including clinical criteria for diagnosis. MOVEMENT DISORD , 19 (6) 630 - 640.

Zijlmans, JCM; Debilly, B; Rascol, O; Lees, AJ; Durif, F; (2004) Safety of entacapone and apomorphine co administration in levodopa-treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study. MOVEMENT DISORD , 19 (9) 1006 - 1011. 10.1002/mds.20188.

Zimprich, A; Muller-Myhsok, B; Farrer, M; Leitner, P; Sharma, M; Hulihan, M; ... Gasser, T; + view all (2004) The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval. AMERICAN JOURNAL OF HUMAN GENETICS , 74 (1) 11 - 19. 10.1086/380647.

This list was generated on Sun Jul 27 07:34:30 2014 BST.